Stockscreener 앱 받기
6.49
6.39%
0.39
시간 외 거래:
6.50
0.010
+0.15%
전일 마감가:
$6.10
열려 있는:
$6.35
하루 거래량:
173.66K
Relative Volume:
1.36
시가총액:
$224.94M
수익:
$4.71M
순이익/손실:
$-46.77M
주가수익비율:
-3.8649
EPS:
-1.6792
순현금흐름:
$-60.34M
1주 성능:
+7.99%
1개월 성능:
+6.74%
6개월 성능:
-34.77%
1년 성능:
-33.50%
1일 변동 폭
$6.19
$6.5499
1주일 범위
$5.81
$6.5499
52주 변동 폭
$5.55
$12.21
Nyxoah Sa Stock (NYXH) Company Profile
NYXH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
6.49 | 224.94M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
531.82 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
167.00 | 58.65B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
97.38 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
240.66 | 35.34B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.57 | 16.25B | 3.90B | 392.30M | 288.10M | 1.95 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-31 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2022-04-21 | 개시 | Oppenheimer | Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2021-12-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Nyxoah Sa 주식(NYXH)의 최신 뉴스
Nyxoah S.A. (NASDAQ:NYXH) Shares Bought by Geode Capital Management LLC - Defense World
LPL Financial LLC Buys Shares of 12,700 Nyxoah S.A. (NASDAQ:NYXH) - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph
Press Release Distribution & PR Platform - ACCESS Newswire
Stifel cuts Nyxoah stock price target to $14, maintains Buy rating - Investing.com Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect - markets.businessinsider.com
Nyxoah Announces Conditional Issuance of 5 Million Shares - TipRanks
Nyxoah Expands ATM Program: 5.66M Total Shares Now Available for Market Sale - Stock Titan
Conditional Issuance of Shares - The Manila Times
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect - markets.businessinsider.com
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Nyxoah’s Final Hurdle for FDA Approval of Genio Neurostimulator for Sleep Apnea - sleepreviewmag.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation - ACCESS Newswire
Nyxoah Expects to Meet Final FDA Requirements for Sleep Apnea Treatment Device Approval in Q2 - MarketScreener
FDA Signals Green Light for Revolutionary Sleep Apnea TreatmentJust One Step Away - Stock Titan
Nyxoah Expects Q2 Approval of Genio System from US FDA - MarketScreener
Nyxoah Provides Update on FDA Approvable Letter for Genio System - The Manila Times
Nyxoah Provides Update On FDA Approvable Letter For Genio System - MarketScreener
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out - markets.businessinsider.com
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Invest - GuruFocus
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks By Investing.com - Investing.com South Africa
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks - Investing.com
Nyxoah S.A. Investors: Company Investigated By The Portnoy Law Firm - menafn
HC Wainwright Comments on Nyxoah’s Q1 Earnings (NASDAQ:NYXH) - Defense World
Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00 - Defense World
Nyxoah SA: A Medical Technology Company with a Big Loss - RagingBull
Nyxoah announces FDA approvable letter for Genio pre-market approval application - TipRanks
Nyxoah Says FDA Issues Approvable Letter for Genio System - MarketScreener
FDA Issues Approvable Letter For Nyxoah's Genio® System - TradingView
Nyxoah Sa (NYXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
자본화:
|
볼륨(24시간):